Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases

BACKGROUND: Primary tumor resection (PTR) as a treatment option for patients with stage IV pancreatic cancer (PC) is controversial. PATIENTS AND METHODS: Stage IV PC patients, with treatment data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER), were scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Ningzhen, Jiang, Yu, Weng, Yuanchi, Chen, Hao, Deng, Xiaxing, Shen, Baiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419755/
https://www.ncbi.nlm.nih.gov/pubmed/34288562
http://dx.doi.org/10.1002/cam4.4147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419755/
https://www.ncbi.nlm.nih.gov/pubmed/34288562
http://dx.doi.org/10.1002/cam4.4147

Ejemplares similares